Jennifer Fitzpatrick

CIK: 0002061851

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (33.3%)

Position reduction

Option Exercises (M)4 (33.3%)

Derivative conversions

Awards (A)3 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (8.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SION

Sionna Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

SION
Sionna Therapeutics, Inc.
Sep 17, 2026
Award(A)
Direct
28.1K shares-
SION
Sionna Therapeutics, Inc.
Sep 17, 2026
Disposition(D)
Non-Qualified Stock Option (right to buy)
Direct
103.1K shares-
SION
Sionna Therapeutics, Inc.
Sep 17, 2026
Award(A)
Direct
28.1K shares-
SION
Sionna Therapeutics, Inc.
Jul 6, 2026
Exercise(M)
Direct
10.3K shares at avg. $6.11$63K
SION
Sionna Therapeutics, Inc.
Jul 6, 2026
Sale(S)
Direct
10.3K shares at avg. $43.60$447K
SION
Sionna Therapeutics, Inc.
Mar 5, 2026
Sale(S)
Direct
10.3K shares at avg. $33.86$347K
SION
Sionna Therapeutics, Inc.
Mar 5, 2026
Exercise(M)
Direct
10.3K shares at avg. $6.11$63K
SION
Sionna Therapeutics, Inc.
Jan 2, 2026
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
103.1K shares-
SION
Sionna Therapeutics, Inc.
Dec 5, 2025
Sale(S)
Direct
10.3K shares at avg. $40.52$415K
SION
Sionna Therapeutics, Inc.
Dec 5, 2025
Exercise(M)
Direct
10.3K shares at avg. $6.11$63K
SION
Sionna Therapeutics, Inc.
Sep 4, 2025
Sale(S)
Direct
10.3K shares at avg. $23.12$237K
SION
Sionna Therapeutics, Inc.
Sep 4, 2025
Exercise(M)
Direct
10.3K shares at avg. $6.11$63K

		Type	Shares	Price		Ownership
Sep 17, 2026	SION Sionna Therapeutics, Inc.	Award(A)	28,133	-	$0	Direct
Sep 17, 2026	SION Sionna Therapeutics, Inc.	Disposition(D) Non-Qualified Stock Option (right to buy)	103,140	-	-	Direct
Sep 17, 2026	SION Sionna Therapeutics, Inc.	Award(A)	28,132	-	$0	Direct
Jul 6, 2026	SION Sionna Therapeutics, Inc.	Exercise(M)	10,250	$6.11	$62,628	Direct
Jul 6, 2026	SION Sionna Therapeutics, Inc.	Sale(S)	10,250	$43.60	$446,862	Direct
Mar 5, 2026	SION Sionna Therapeutics, Inc.	Sale(S)	10,250	$33.86	$347,019	Direct
Mar 5, 2026	SION Sionna Therapeutics, Inc.	Exercise(M)	10,250	$6.11	$62,628	Direct
Jan 2, 2026	SION Sionna Therapeutics, Inc.	Award(A) Non-Qualified Stock Option (right to buy)	103,140	-	-	Direct
Dec 5, 2025	SION Sionna Therapeutics, Inc.	Sale(S)	10,250	$40.52	$415,330	Direct
Dec 5, 2025	SION Sionna Therapeutics, Inc.	Exercise(M)	10,250	$6.11	$62,628	Direct
Sep 4, 2025	SION Sionna Therapeutics, Inc.	Sale(S)	10,250	$23.12	$236,980	Direct
Sep 4, 2025	SION Sionna Therapeutics, Inc.	Exercise(M)	10,250	$6.11	$62,628	Direct

1-12 of 12 transactions

About Fitzpatrick Jennifer

Fitzpatrick Jennifer (SEC CIK 0002061851) files insider reports with the SEC as CLO and Head of Program Mgmt. of Sionna Therapeutics, Inc. (SION).

Signal8 holds 7 ownership filings by Fitzpatrick Jennifer (1 Form 3, 6 Form 4), filed between Apr 1, 2025 and Sep 18, 2026. Those filings report 12 transactions, from Sep 4, 2025 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fitzpatrick Jennifer's filings is in WALTHAM, MA.

Recent filings by Fitzpatrick Jennifer

Sep 17, 2026: Grant or award of SION shares (Form 4, code A).
Sep 17, 2026: Disposition to issuer transaction of SION derivative securities (Form 4, code D).
Sep 17, 2026: Grant or award of SION shares (Form 4, code A).
Jul 6, 2026: Option exercise of SION shares (Form 4, code M).
Jul 6, 2026: Open-market sale of SION shares (Form 4, code S).

Other insiders filing for Sionna Therapeutics, Inc. (SION)

RA CAPITAL MANAGEMENT, L.P., Director
Ridloff Elena, CFO and CBO
McKee Charlotte, CMO and Head of R&D
Cloonan Michael, President & CEO
Thompson Peter A., Director
ORBIMED ADVISORS LLC, Director

How to read Form 4 transaction codes